Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Ginkgo Bioworks Hldgs Inc (DNA)

Ginkgo Bioworks Hldgs Inc (DNA)
12.00 x 27 12.99 x 2
Post-market by (Cboe BZX)
12.28 +0.46 (+3.89%) 01/28/25 [NYSE]
12.00 x 27 12.99 x 2
Post-market 12.35 +0.07 (+0.57%) 19:50 ET
Quote Overview for Tue, Jan 28th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
11.53
Day High
12.61
Open 11.96
Previous Close 11.82 11.82
Volume 859,400 859,400
Avg Vol 1,346,005 1,346,005
Stochastic %K 66.67% 66.67%
Weighted Alpha -73.35 -73.35
5-Day Change +0.70 (+6.04%) +0.70 (+6.04%)
52-Week Range 5.26 - 64.40 5.26 - 64.40
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 679,402
  • Shares Outstanding, K 57,479
  • Annual Sales, $ 251,460 K
  • Annual Income, $ -892,870 K
  • EBIT $ -586 M
  • EBITDA $ -515 M
  • 60-Month Beta 1.09
  • Price/Sales 2.77
  • Price/Cash Flow N/A
  • Price/Book 0.89

Options Overview Details

View History
  • Implied Volatility 119.26% ( -0.59%)
  • Historical Volatility 109.97%
  • IV Percentile 57%
  • IV Rank 23.08%
  • IV High 354.68% on 08/19/24
  • IV Low 48.61% on 03/27/24
  • Put/Call Vol Ratio 0.30
  • Today's Volume 626
  • Volume Avg (30-Day) 2,651
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 105,812
  • Open Int (30-Day) 178,158

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -1.45
  • Number of Estimates 2
  • High Estimate -1.43
  • Low Estimate -1.47
  • Prior Year -3.60
  • Growth Rate Est. (year over year) +59.72%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.44 +45.50%
on 01/14/25
Period Open: 9.66
14.24 -13.76%
on 01/24/25
+2.62 (+27.12%)
since 12/27/24
3-Month
6.01 +104.33%
on 11/15/24
Period Open: 8.27
14.24 -13.76%
on 01/24/25
+4.01 (+48.49%)
since 10/28/24
52-Week
5.26 +133.46%
on 09/10/24
Period Open: 51.60
64.40 -80.93%
on 02/29/24
-39.32 (-76.20%)
since 01/26/24

Most Recent Stories

More News
Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today

The company is forging ahead with next-generation drug development solutions.

GOOGL : 195.30 (+1.82%)
GOOG : 197.07 (+1.70%)
DNA : 12.28 (+3.89%)
Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors?

Could this beaten-down stock turn things around in the near future?

MRK : 97.45 (-0.50%)
NVO : 85.19 (-2.65%)
GOOGL : 195.30 (+1.82%)
GOOG : 197.07 (+1.70%)
DNA : 12.28 (+3.89%)
2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock

The risks may resolve in a year or so but seizing the opportunities will take longer.

DNA : 12.28 (+3.89%)
This 1 AI Stock Could Revolutionize Biotech and Pharma

The company is using artificial intelligence, and planning to help others use AI empowered by its data collection.

DNA : 12.28 (+3.89%)
Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock?

Its ambitious business model may not be sustainable.

DNA : 12.28 (+3.89%)
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now?

Have shares of the troubled life sciences business fallen too far?

DNA : 12.28 (+3.89%)
Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocks

Efficiency in core processes is set to increase substantially due to AI.

RXRX : 7.43 (+5.69%)
DNA : 12.28 (+3.89%)
Down 81% in 2024, Is Ginkgo Bioworks Stock Still a Buy?

A recovery plan is underway, but it isn't a slam dunk.

DNA : 12.28 (+3.89%)
Why Ginkgo Bioworks Stock Is Sinking Today

There was double trouble for this beaten-down biotech stock.

DNA : 12.28 (+3.89%)
ARKK : 61.93 (+2.03%)
ARKG : 26.66 (+0.38%)
Bull Market and Beyond: 3 Stocks Just Waiting to Soar

These pharma and biotech players could become long-term winners.

SNY : 52.97 (-0.69%)
NVAX : 9.52 (+2.15%)
PFE : 26.75 (-0.41%)
DNA : 12.28 (+3.89%)

Business Summary

Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 13.84
2nd Resistance Point 13.23
1st Resistance Point 12.75
Last Price 12.28
1st Support Level 11.67
2nd Support Level 11.06
3rd Support Level 10.58

See More

52-Week High 64.40
Fibonacci 61.8% 41.81
Fibonacci 50% 34.83
Fibonacci 38.2% 27.85
Last Price 12.28
52-Week Low 5.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar